Amyotrophic Lateral Sclerosis Classification and Characteristics

Clinical Presentation

The American Academy of Neurology notes that ALS is classified into two main clinical presentation types based on site of onset: bulbar-onset ALS (25-35% of cases) and limb-onset/spinal ALS (65-75% of cases) 1, 2, 3
Bulbar-onset ALS accounts for 25-35% of all ALS patients and presents with initial symptoms affecting speech and swallowing 1, 2
Approximately 80% of bulbar-onset patients develop dysarthria (speech difficulty) and dysphagia (swallowing difficulty) as primary manifestations 1, 2, 4, 5
Limb-onset/spinal ALS represents the majority of ALS cases (65-75%) with initial symptoms in the extremities 1, 2
Primary manifestation of limb-onset/spinal ALS is progressive muscle weakness in arms or legs 2
Spinal motor neuron injury leads to peripheral muscle weakness and atrophy in limb-onset/spinal ALS patients 1, 2

The American College of Radiology states that sporadic ALS represents approximately 85-90% of all ALS cases 6, 7, 3, 5
Sporadic ALS occurs without known genetic mutation or family history 3
Annual incidence of sporadic ALS is 1-2 per 100,000 people 6, 7, 5
Etiology of sporadic ALS is multifactorial, involving oxidative stress, glutamate toxicity, mitochondrial dysfunction, inflammation, and apoptosis 1, 2, 4

The American Academy of Neurology notes that mean survival of typical progressive ALS is 3-5 years after symptom onset 2, 3, 4, 5
Respiratory failure and malnutrition with dehydration are primary causes of death in typical progressive ALS patients 2
Slowly progressive ALS is associated with longer survival of 5-10 years from symptom onset 3
Only 5-10% of patients live longer than 10 years 2, 3, 4, 5

Cognitive dysfunction occurs in 20-50% of ALS cases, mainly frontotemporal dementia 1, 2
Up to 40-50% of patients have extra-motor manifestations including behavioral changes, executive dysfunction, and language problems 4
Diagnostic delays are common due to heterogeneous presentation and overlap with other neurological conditions 3
Definitive biomarkers for ALS are still lacking, complicating early diagnosis 3
All ALS types require multidisciplinary approach with supportive and palliative care from time of diagnosis 4, 5
Early diagnosis and intervention are crucial for improving outcomes and quality of life 3
Nutritional support is essential, particularly for bulbar-onset patients with dysphagia and weight loss 4

Atypical presentations of ALS, such as asymmetric or predominantly proximal/distal weakness, can delay diagnosis, and severe diffuse pain may precede weakness, mimicking other conditions, according to the American Academy of Neurology 8
Young children may present with nonspecific features like refusal to bear weight or irritability, and in pure motor variants with AMAN subtype, reflexes may be normal or even exaggerated rather than diminished, contradicting the typical pattern, as noted by the American Academy of Neurology 8
Symptom onset in less than 24 hours suggests stroke or other acute process, and progression to maximum disability after more than 4 weeks should prompt consideration of other diagnoses, as recommended by the American Academy of Neurology 8